General Mills
GIS
$34.27
-0.70%
General Mills, Inc. is a global packaged-food company operating in the Consumer Defensive sector, producing a wide portfolio of snacks, cereal, convenient meals, baking mixes, dough, pet food, and superpremium ice cream under iconic brands like Cheerios, Nature Valley, and Haagen-Dazs. The company is a dominant, established player in the mature packaged foods industry, competing on brand strength, scale, and distribution. The current investor narrative is dominated by a challenging operating environment, as evidenced by recent revenue declines and a strategic portfolio sharpening, including the exit of its Brazilian business, with the stock's deep underperformance reflecting concerns over growth, margins, and its ability to navigate inflationary cost pressures.…
GIS
General Mills
$34.27
Related headlines
Investment Opinion: Should I buy GIS Today?
Rating: Hold. The core thesis is that GIS is a deeply out-of-favor, high-yield value trap where severe fundamental headwinds are balanced against a historically cheap valuation and a sustainable dividend, resulting in a neutral risk/reward profile absent a clear turnaround catalyst.
Supporting evidence includes a forward P/E of 10.9x, a 37% discount to its 52-week high, and a dividend yield of 4.5% funded by robust $1.65B in TTM FCF. However, these are offset by negative revenue growth (-8.4%), gross margin compression (down 423 bps YoY in Q3), and elevated financial leverage (D/E of 1.66). The stock trades at a discount to sector peers, but this discount is justified by its weaker growth and profitability profile.
The thesis would upgrade to a Buy if the company demonstrates sequential revenue stabilization and gross margin improvement above 32% for two consecutive quarters, signaling the inflationary pressure is abating. It would downgrade to a Sell if revenue decline accelerates beyond -10% YoY, the dividend payout ratio exceeds 80%, or the stock breaks decisively below the $31.75 support level. Relative to its own challenged history and peers, the stock is fairly valued, reflecting a balance between deep pessimism and lack of near-term growth catalysts.
Sign up to view all
GIS 12-Month Price Forecast
The outlook for GIS is one of challenged stability. The severe fundamental pressures are real and justify the stock's deep underperformance. However, the current valuation appears to reflect much of this pessimism, and the high dividend provides a floor. The most likely path (Base Case, 60% probability) is a continued period of stagnation with the stock range-bound. The stance would upgrade to Bullish on concrete evidence of margin recovery and revenue stabilization for two consecutive quarters. It would turn Bearish if the dividend coverage weakens (FCF payout ratio >90%) or if technical support at $31.75 fails.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on General Mills's 12-month outlook, with a consensus price target around $44.55 and implied upside of +30.0% versus the current price.
Average Target
$44.55
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$27 - $45
Analyst target range
Insufficient analyst coverage available. The provided data indicates only 2 analysts providing estimates, and while institutional ratings show coverage from major firms, a consolidated consensus recommendation and average target price are not provided in the dataset. This limited explicit consensus coverage, despite visible institutional ratings, can be typical for a large-cap but out-of-favor stock where estimates may be in flux, leading to higher volatility and less efficient price discovery as the market grapples with the company's evolving narrative.
Bulls vs Bears: GIS Investment Factors
The bear case currently holds stronger evidence, grounded in concrete, deteriorating fundamentals: accelerating revenue decline (-8.4% YoY) and severe gross margin compression (306 bps quarter-over-quarter). The bull case rests primarily on a deep valuation discount and a high, cash-flow-supported dividend, which are defensive attributes rather than catalysts for growth. The single most important tension in the investment debate is whether the current valuation (12.9x trailing P/E) adequately discounts the risk of a prolonged period of top-line shrinkage and margin erosion, or if it represents an overreaction that creates a value opportunity for patient income investors. The resolution hinges on management's ability to stabilize revenues and halt the margin bleed in upcoming quarters.
Bullish
- Deep Valuation Discount to Peers: GIS trades at a trailing P/E of 12.9x and a forward P/E of 10.9x, a significant discount to the typical mid-to-high teens multiples for stable packaged food peers. This valuation compression, with the stock near multi-year lows, suggests substantial pessimism is already priced in, creating a potential margin of safety for value investors.
- Robust Free Cash Flow Supports Dividend: The company generates strong trailing twelve-month free cash flow of $1.65 billion, which comfortably funds its attractive 4.5% dividend yield. This high yield, supported by a sustainable payout ratio of 58.3%, provides a tangible return while investors wait for a potential operational turnaround.
- Strategic Portfolio Sharpening: Recent actions like the exit of its Brazilian business demonstrate management's focus on streamlining operations and concentrating on core, higher-margin brands. This strategic pivot, while contributing to near-term revenue declines, is a necessary step to improve long-term profitability and capital allocation.
- Oversold Technical Condition: The stock is down 37% over the past year and trades just 8.7% above its 52-week low of $31.75, having experienced a maximum drawdown of -41.7%. This severe underperformance, coupled with a negative 1-year relative strength of -59.8% versus the S&P 500, indicates an oversold condition that could precede a technical bounce.
Bearish
- Severe Revenue Contraction and Margin Pressure: Q3 revenue of $4.44B declined 8.4% YoY, accelerating from the prior quarter. Concurrently, gross margin collapsed to 30.6% from 34.8% in Q2, highlighting intense cost inflation and an inability to pass costs to consumers, directly threatening the core profitability model.
- Elevated Financial Leverage and Liquidity Strain: A debt-to-equity ratio of 1.66 indicates significant leverage, while a current ratio of 0.67 signals potential difficulty meeting short-term obligations. This financial structure increases risk if operational pressures persist, potentially limiting strategic flexibility and amplifying downside.
- Persistent Fundamental Deterioration Trend: The negative revenue growth, margin compression, and 37% stock decline are not isolated events but part of a sustained downtrend. The stock's atypical negative beta of -0.041 confirms these are company-specific, not macro, headwinds, suggesting the problems are deep-rooted.
- Limited Analyst Coverage and Guidance Uncertainty: With only 2 analysts providing estimates, there is less consensus and price discovery, increasing volatility. The lack of a clear analyst average target price reflects high uncertainty about the company's near-term trajectory and the success of its turnaround efforts.
GIS Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -36.96%, significantly underperforming the broader market. As of the latest close at $34.51, the price is trading near the bottom of its 52-week range, approximately 10% above the 52-week low of $31.75 and 37% below the 52-week high of $55.13; this positioning near multi-year lows suggests the market is pricing in substantial fundamental deterioration, presenting a potential value trap rather than a clear-cut opportunity. Recent momentum shows a slight short-term bounce but remains weak within the context of the longer-term decline, with a 1-month gain of 2.68% and a 3-month loss of -12.37%; this divergence indicates a tentative stabilization or oversold bounce, but the stock's relative strength versus the S&P 500 remains deeply negative at -59.82% over one year, signaling persistent and severe weakness. Key technical support is clearly defined at the 52-week low of $31.75, while resistance sits at the recent breakdown level near the 52-week high of $55.13; a decisive break below $31.75 would likely trigger another leg down, while the stock's beta of -0.041 indicates it has exhibited an inverse, defensive correlation to the market during this period, which is atypical for a consumer staple and underscores its unique, company-specific headwinds.
Beta
-0.04
-0.04x market volatility
Max Drawdown
-41.6%
Largest decline past year
52-Week Range
$32-$54
Price range past year
Annual Return
-36.0%
Cumulative gain past year
| Period | GIS Return | S&P 500 |
|---|---|---|
| 1m | +3.9% | +2.1% |
| 3m | -11.5% | +12.5% |
| 6m | -29.5% | +12.4% |
| 1y | -36.0% | +26.4% |
| ytd | -25.0% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
GIS Fundamental Analysis
Revenue growth has turned negative, indicating significant top-line pressure; the most recent quarterly revenue for Q3 2026 was $4.44 billion, representing an 8.4% year-over-year decline, and this follows a sequential drop from $4.86 billion in Q2, pointing to accelerating revenue contraction rather than stabilization. The company remains profitable but margins are under severe pressure; net income for the quarter was $303 million, with a net margin of 6.8%, while the gross margin compressed sharply to 30.6%, down from 34.8% in the prior quarter, highlighting intense cost inflation and an inability to fully pass it on to consumers. The balance sheet shows elevated leverage and strong cash generation, with a debt-to-equity ratio of 1.66 indicating significant financial leverage, but this is partially offset by robust trailing twelve-month free cash flow of $1.65 billion, which supports the current dividend yield of 4.5% and provides internal funding flexibility; however, the current ratio of 0.67 suggests potential liquidity strain in covering short-term obligations.
Quarterly Revenue
$4.4B
2026-02
Revenue YoY Growth
-0.08%
YoY Comparison
Gross Margin
+0.30%
Latest Quarter
Free Cash Flow
$1.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is GIS Overvalued?
Given the positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 12.9x, while the forward PE is 10.9x, indicating the market expects modest earnings growth or recovery in the coming year. Compared to sector averages, GIS trades at a discount; for instance, its trailing PE of 12.9x is below the typical range for stable packaged food peers, which often trade in the mid-to-high teens, suggesting the market is discounting its growth prospects and margin challenges. Historically, the stock's own valuation has compressed significantly; the current trailing PE of 12.9x is near the bottom of its multi-year range, as historical data shows PE ratios previously above 20x, indicating the market has de-rated the stock due to the fundamental pressures, leaving it trading at a level that may already reflect significant pessimism.
PE
12.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 6x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The company faces a dual threat of revenue contraction (-8.4% YoY) and severe margin pressure, with gross margin falling to 30.6% in Q3 from 34.8% in Q2. This directly impacts profitability, as net margin compressed to 6.8%. Elevated leverage, with a debt-to-equity ratio of 1.66, compounds these risks, and a weak current ratio of 0.67 indicates potential liquidity strain. The high 81% revenue concentration in the U.S. market also limits geographic diversification benefits.
Market & Competitive Risks include valuation compression in a sector where GIS already trades at a discount. If growth concerns persist, the P/E multiple could re-rate further from its current 12.9x. The stock's negative beta of -0.041 indicates it has moved inversely to the market recently, losing its traditional defensive staple characteristic, which may deter a key investor base. External threats like sustained input cost inflation, highlighted by recent news on surging fertilizer prices, could prolong margin pressure. Competitive intensity from private label and shifting consumer preferences also poses a persistent headwind.
Worst-Case Scenario involves a failure to stabilize operations, leading to consecutive quarters of revenue declines and further margin erosion. This could trigger a dividend cut if free cash flow weakens, breaking a key support for the stock. A breach of the key technical support at the 52-week low of $31.75 could catalyze accelerated selling. In this adverse scenario, a realistic downside from the current price of $34.51 is approximately -20% to the $27-$28 range, extrapolating from the stock's historical max drawdown of -41.7% and applying further multiple compression on declining earnings.
FAQ
The key risks are, in order of severity: 1) Operational Deterioration: Accelerating revenue decline (-8.4% YoY) and gross margin collapse (down to 30.6%) threaten the profit model. 2) Financial Leverage: A debt-to-equity ratio of 1.66 increases vulnerability to rising rates and earnings volatility. 3) Dividend Sustainability Risk: While currently covered by FCF, prolonged earnings weakness could pressure the 4.5% yield, a key support for the stock. 4) Market Sentiment: The stock has shown an inverse correlation to the market (beta -0.041), losing its defensive status, which could lead to continued underperformance even in a stable macro environment.
Our 12-month forecast outlines three scenarios. The Base Case (60% probability) sees the stock trading between $35 and $40, assuming continued struggles but no further major deterioration. The Bull Case (25% probability) targets $45-$50 on successful margin recovery and stabilization. The Bear Case (15% probability) warns of a drop to $28-$32 if operational decline accelerates. The Base Case is most likely, predicated on the assumption that revenue declines moderate but margins remain under persistent pressure, keeping the valuation multiple depressed. The lack of a clear analyst consensus average target adds to the forecast uncertainty.
GIS is fairly valued relative to its current challenged fundamentals but historically undervalued. Its trailing P/E of 12.9x and forward P/E of 10.9x are below the typical range for packaged food peers, suggesting a market discount. However, this discount is justified by its negative growth and compressed margins. Compared to its own history, where P/E ratios were above 20x, it is deeply undervalued. The current valuation implies the market expects continued earnings pressure and minimal growth. It is not screamingly cheap on an absolute basis, but it is priced for significant pessimism.
GIS is a high-risk, potentially high-reward stock for a specific investor profile. It is not a 'good buy' for most growth or conservative investors due to its -8.4% revenue decline and severe margin pressure. However, for deep-value, income-focused investors with a multi-year horizon, the 4.5% dividend yield (supported by $1.65B in FCF) and a forward P/E of 10.9x (a discount to peers) may present a compelling, though speculative, opportunity. The biggest risk is that the operational deterioration continues, making the current valuation a 'value trap.' It could be a good buy only for those willing to absorb further downside for the chance of a slow turnaround.
GIS is strictly a long-term investment for patient capital. The company is in the midst of a significant operational transition and facing intense cost pressures; a turnaround will take multiple quarters, if not years. The high dividend yield is suited for long-term income accumulation. The stock's high volatility (evidenced by a -41.7% max drawdown) and lack of near-term positive catalysts make it unsuitable for short-term trading. A minimum holding period of 3-5 years is suggested to allow for the execution of its strategic portfolio review and for potential margin recovery, while collecting the dividend throughout.